{
    "title": "US pulls GSK's COVID drug as omicron sibling dominates cases",
    "url": "https://www.dailymail.co.uk/wires/ap/article-10689439/US-pulls-GSKs-COVID-drug-omicron-sibling-dominates-cases.html",
    "date": "2022-04-05",
    "keywords": [
        "drug",
        "antibody",
        "covid19",
        "omicron",
        "health",
        "companys",
        "fda",
        "disease",
        "use",
        "ap",
        "subvariant",
        "food",
        "administration",
        "sotrovimab",
        "decision",
        "version",
        "glaxo",
        "coronavirus",
        "ba2",
        "virus",
        "science",
        "department",
        "washington",
        "state",
        "territory",
        "northeast",
        "control",
        "prevention",
        "tuesday",
        "surge",
        "case",
        "codeveloper",
        "vir",
        "biotechnology",
        "medication",
        "mutating",
        "eli",
        "authorization",
        "january",
        "signature",
        "spike",
        "pfizer",
        "merck",
        "pharmacy",
        "glaxosmithkline",
        "logo",
        "wednesday",
        "country",
        "rourke",
        "government",
        "worth",
        "fall",
        "month",
        "dose",
        "request",
        "ok",
        "body",
        "invader",
        "infection",
        "risk",
        "death",
        "heart",
        "press",
        "support",
        "howard",
        "education",
        "content"
    ],
    "category": [
        "wires",
        "ap"
    ]
}